Profile image
Story Views

Last Hour:
Last 24 Hours:

Europe Continuous Glucose Monitoring Systems Market by Component (Sensors, Transmitters & Receivers, and Integrated Insulin Pumps)

Wednesday, February 15, 2017 3:36
% of readers think this story is Fact. Add your two cents.

(Before It's News) include new market research report “Continuous Glucose Monitoring Systems Market” Attractiveness, Competitive Landscape and Forecasts” to its huge collection of research reports

Request sample copy:

Continuous glucose monitoring (CGM) is a latest technological advancement in the field of diabetes management. CGM system is a type of device that monitors glucose by a biosensor, which is inserted through the transcutaneous or subcutaneous route. This embedded sensor measures glucose levels in interstitial fluid or blood, and transmits the information using a transmitter to a receiver/monitor to display the results. The use of CGM systems is crucial to avoid diabetic complications, as this technology can be used to periodically monitor the glucose levels.

Enquire about report @

The market is categorized based on component, demographics, end user, and country. The component segment includes durable components such as transmitters & receivers and integrated insulin pumps; and disposable components such as sensors. Sensors occupy a dominant share in the European CGMS market owing to short life span of these devices, recurring sales of CGMS, and bulk purchases. Therefore, they are deployed in diagnostic centers/clinics. Moreover, the adoption of CGMS in hospital ICUs and in-home healthcare settings has increased in recent years. End users of CGMS devices are diabetic patients, categorized into child population (≤14 years) and adult population (>14 years).

Browse full report @

Major strategies adopted by market players are collaborations, product launches, and product approvals. Agreement/partnership strategy by companies enables greater focus on innovation, distribution, and commercialization of devices. For instance, in 2016, Senseonics signed an agreement with Roche to commercialize Senseonics’ Eversense continuous glucose monitoring system. Under this agreement, Roche can sell its CGM systems in Germany, Italy, and the Netherlands


  • In-depth and country-level analysis provides the current trends and future estimations in the European CGMS market from 2014 to 2022, which would enable stakeholders to capitalize on the prevailing market opportunities.
  • Comprehensive analysis of factors that drive and restrict the growth of the market is provided.
  • In-depth analysis of current research and clinical developments within the European CGMS market is provided along with the key dynamic factors.
  • The key players in the European CGMS market are profiled, along with their development strategies, to understand the competitive outlook.

About Big Market Research:

Big Market Research uniqueness lies in its highly ethical reports at economical rates because we value your relationship and growth more than money. Your growth is our aim.

Our strength is in our research analysts who with their proactive approach can source best and correct information which can be detrimental in organizations success. We follow six sigma standards leaving no scope for error.

Contact Big Market Research:

Direct Contact: + 1-503-894-6022
Toll Free: + 1-800-910-6452

Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.